There are 3 keys to success when developing a patient engagement program.
Nurses today are in an optimal position to help pharma companies. Dr. Adele Mueller shares how empowering nurses empowers patients.
Another update from Bart Cobert regarding the ongoing Brexit saga.
The Brexit saga continues. Here Bart Cobert highlights new Brexit developments with regard to the EMA.
Bart Cobert examines the importance of, and differences between Data Monitoring Committees (DMCs) & Safety Assessment Committees (SACs).
Bart Cobert reviews the key requirements for the US-EU Privacy Shield, including implications for US Firms, Pharma Companies, and Drug Safety & Pharmacovigilance
Exploring the role of the Medical Monitor in the clinical research process.
When developing a patient engagement program, focus on the patient.
Bart Cobert reviews the HIPAA and current EU data privacy system and their impacts on drug safety and PV.
